Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Alzheimer Disease
Clinical trial register · Japan

Alzheimer Disease Trials in Japan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Bunkyō City 7 Ōbu 7 Chūōku 3 Osaka 3 Hadano 3

Alzheimer Disease trials in Japan

16 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Not yet open
A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)
NCT07843459Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid
Eli Lilly and Company
Phase 1
111
Bunkyō City, Ōbu
2026-10
Recruiting
Eli Lilly and Company
Phase 1
179
Bunkyō City, Ōbu
2026-09-09
Recruiting
Eli Lilly and Company
Phase 3
550
Chūōku, Hachiōji, Ōbu, Shinjuku, Shinjyuku, tabashi City
2026-05-22
Recruiting
Bristol-Myers Squibb
Phase 3
325
Suita, Nankoku-shi, Osaka
2026-03-25
Recruiting
Bristol-Myers Squibb
Phase 3
650
Hadano, Kawasaki, Sakai, Kanzaki-Gun Yoshinogari-Cho, Karatsu-shi, Bunkyo-ku, Fukuoka, Okayama
2025-12-02
Recruiting
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
NCT07787182Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid
Eli Lilly and Company
Phase 1
68
Bunkyō City, Ōbu
2025-10-14
Recruiting
Eli Lilly and Company
Phase 3
3,400
Bunkyō City, Tokyo
2025-08-25
Recruiting
Bristol-Myers Squibb
Phase 3
426
Hadano, Kawasaki, Sakai, Kanzaki-Gun Yoshinogari-Cho, Karatsu-shi, Bunkyo-ku, Fukuoka, Okayama
2025-07-10
Recruiting
Otsuka Pharmaceutical Co., Ltd.
Observational
200
Osaka
2025-04-17
Recruiting
Eli Lilly and Company
Phase 1
128
Bunkyō City, Ōbu
2024-10-29
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Iizuka, Kōriyama, Sapporo, Himeji-Shi, Toride-shi, Takamatsu, Hadano, Kawasaki-Shi
2024-09-26
Recruiting
Eli Lilly and Company
Phase 1
56
Bunkyō City
2024-08-15
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 2
55
Chofu-shi, Chūōku, Hirakata-shi, Kobe, Musashimurayama, Narashino-shi, Shinjuku Ku, Shinjuku-ku
2024-07-22
Active, closed
Eli Lilly and Company
Phase 3
2,996
Bunkyō City, Chūōku, Hachiōji, Osaka, Ōbu, Shinjuku, Shinjuku-ku, Suita-shi
2021-08-27
Active, closed
Eli Lilly and Company
Phase 3
1,736
Nagoya, Ōbu, Inage, Akashi, Himeji, Kobe, Inashiki, Toride
2020-06-19
Recruiting
The Chinese Familial Alzheimer's Network
NCT03657732Alzheimer Disease, Familial Alzheimer Disease (FAD)
Capital Medical University
Observational
40,000
2005-01-10
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-japan/condition/alzheimer-disease

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies listing the condition Alzheimer Disease.

How many Alzheimer Disease trials are recruiting in Japan?

12 of the 16 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Alzheimer Disease), 16 studies
PhaseStudiesRecruitingShare
Phase 38650%
Phase 15431.3%
Observational2212.5%
Phase 2106.3%

Most active sponsors

Lead sponsors with the most studies (Alzheimer Disease)
Lead sponsorStudiesRecruiting
Eli Lilly and Company96
Bristol-Myers Squibb33
Capital Medical University11
Janssen Pharmaceutica N.V., Belgium10
Karuna Therapeutics, Inc., a Bristol Myers Squibb company11
Otsuka Pharmaceutical Co., Ltd.11
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.